Zota Health Care (ZOTA.NS) Earnings Analysis
Zota Health Care (ZOTA.NS) next reports earnings on 2026-08-10. Last quarter (2026-05-22) it beat with EPS -4.4 INR vs -18.4 INR est (+76.1%). It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E -54.74.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ZOTA.NS next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 1.97B |
ZOTA.NS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-22 | -4.4 INR | -18.4 INR | +76.1% | Beat |
| 2026-02-04 | -8.9 INR | n/a | n/a | n/a |
| 2025-05-29 | -4.69 INR | n/a | n/a | n/a |
| 2024-11-14 | -4.57 INR | n/a | n/a | n/a |
| 2024-08-14 | -4.8 INR | n/a | n/a | n/a |
Beat rate: 1/1 (100%) over reported quarters with consensus data.
ZOTA.NS valuation and analyst view
| Trailing P/E | -54.74 |
|---|---|
| Trailing EPS | -21.55194 INR |
| Price / book | 6.42 |
| Dividend yield | 0.08% |
| Market cap | 38.75B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Zota Health Care (ZOTA.NS)'s next earnings date?
Zota Health Care is next scheduled to report on 2026-08-10 and revenue estimate of 1.97B.
Did ZOTA.NS beat earnings last quarter?
In its 2026-05-22 report, ZOTA.NS posted EPS of -4.4 INR versus a -18.4 INR estimate — a beat of 76.1%.
What is ZOTA.NS's earnings track record?
Over the last 1 reported quarters with consensus data, ZOTA.NS beat estimates 1 times (100%).
What is ZOTA.NS's current P/E ratio and EPS?
ZOTA.NS trades at a trailing P/E of -54.74 on trailing EPS of -21.5519442663091 INR.
What do analysts rate ZOTA.NS?
ZOTA.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.